5 Insightful Analyst Questions From Ingredion's Q4 Earnings Call

Ingredion’s fourth quarter results drew a positive market response, despite revenue and non-GAAP profit falling short of Wall Street expectations. Management attributed the operational challenges largely to production issues at the Argo facility, which led to reduced inventory and lower sales in the Food and Industrial Ingredients U.S./Canada segment. CEO James Zallie highlighted ongoing strength in the Texture and Healthful Solutions segment, especially clean label and solutions-driven sales. Zallie explained, “Texture and Healthful Solutions posted its seventh straight quarter of volume growth, up 4%,” emphasizing the segment’s momentum even as broader industry sweetener demand remained soft.

Is now the time to buy INGR? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Ingredion’s Q4 Earnings Call

• Kristen Owen (Oppenheimer & Co.) asked for details on the Argo facility’s impact and recovery prospects. CFO Jim Gray clarified that about two-thirds of the Q4 segment decline was due to Argo, with cost recovery expected to phase in through 2026.
• James Cannon (UBS) inquired about LatAm volume shifts and the breakdown of improvement drivers. Gray explained that food and beverage volumes grew while brewing adjunct volumes declined, and highlighted ongoing diversification efforts.
• Benjamin Theurer (Barclays) asked about pricing dynamics and cost coverage in Texture & Healthful Solutions for 2026. CEO James Zallie stated that contracting was completed with flat to slightly down pricing, and gross margin expansion would depend on mix improvements and controlling manufacturing costs.
• Heather Jones (Heather Jones Research LLC) questioned LatAm’s exposure to currency and new Mexican beverage taxes. Gray acknowledged currency headwinds but pointed to potential volume gains from food categories and events like the World Cup offsetting risks.
• Benjamin Mayhew (BMO Capital Markets) queried the timeline for a return to long-term operating income growth targets. Gray responded that margin recovery in U.S./Canada will take time, with a return to 17–18% segment margins possible by 2027–2028, depending on cost and demand trends.

Catalysts in Upcoming Quarters

Looking forward, the StockStory team will be watching (1) the pace of operational recovery and inventory normalization at the Argo facility, (2) the continued adoption and margin impact of clean label and protein fortification products, and (3) the ability of LatAm and Asia Pacific segments to sustain higher-margin growth despite external headwinds. Execution on enterprise productivity initiatives and effective capital allocation will also be important markers of progress.

Ingredion currently trades at $119.30, up from $117.31 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.

Don’t wait for the next volatility shock. Check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.